RenalGuard

by RenalGuard Solutions, Inc.

RenalGuard Therapy®

A Therapeutic Approach to Reducing Contrast-Induced Nephropathy

RenalGuard Therapy® is designed to reduce the toxic effects that contrast media can have on the kidneys, which may lead to a reduction in the incidence of Contrast-Induced Nephropathy (CIN) in at-risk patients. This therapy is based on existing published literature, including the PRINCE study1, which support the theory that creating and maintaining a high urine output through the kidneys allows the body to rapidly eliminate contrast, reducing its toxic effects.

RenalGuard Therapy entails the use of a physician-prescribed loop diuretic which may induce the required high urine output. RenalGuard System is designed to measure urine output and replaces it in real-time with an equal volume of sterile saline. This matched fluid replacement aims to minimize the risk of over- or under-hydration which can lead to increased patient risks.

Highest level of customer service & support, for you.

The founders of EPS Vascular have a combined experience of over fifty years in the cardiovascular business and pride themselves on providing only the highest level of customer service and support.

Our Partners